Do patients (pts) with advanced nonseminomatous germ cell tumors (aNSGCT) and unfavorable time to normalization (TTN) of tumor markers benefit with prolongation of 1-st line chemotherapy (ChT)?
In: Annals of Oncology, Jg. 28 (2017-09-01), S. v324
Online
unknown
Zugriff:
Titel: |
Do patients (pts) with advanced nonseminomatous germ cell tumors (aNSGCT) and unfavorable time to normalization (TTN) of tumor markers benefit with prolongation of 1-st line chemotherapy (ChT)?
|
---|---|
Autor/in / Beteiligte Person: | Fainstein, I. ; Fedyanin, Mikhail ; Tryakin, Alexey ; Tjulandin, S. A. ; Bulanov, A. ; Akhmedov, B. ; Sergeev, J. ; Matveev, Vsevolod ; Zakharova, T. ; Garin, A. |
Link: | |
Zeitschrift: | Annals of Oncology, Jg. 28 (2017-09-01), S. v324 |
Veröffentlichung: | Elsevier BV, 2017 |
Medientyp: | unknown |
ISSN: | 0923-7534 (print) |
DOI: | 10.1093/annonc/mdx371.068 |
Schlagwort: |
|
Sonstiges: |
|